Event Type
Disclosure
Mandatory
Variant
8-K
. RESULTS OF OPERATIONS AND FINANCIAL CONDITION On March 2, 2026, Nuvation Bio Inc. issued a press release announcing its financial results for the quarter ende
FINANCIAL STATEMENTS AND EXHIBITS (d) Exhibits. Exhibit Number Description 99.1 Press Release of Nuvation Bio Inc. dated March 2, 2026. 104 Cover Page Interacti